Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis
NCT04840485 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 548
Last updated 2024-05-22
Summary
The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SHR-1314 in patients with active ankylosing spondylitis
Conditions
Interventions
- DRUG
-
SHR-1314
SHR-1314 high dose
- DRUG
-
SHR-1314
SHR-1314 low-dose
- DRUG
-
Placebo
Sponsors & Collaborators
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-09
- Primary Completion
- 2023-11-03
- Completion
- 2024-02-28
Countries
- China
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis
NCT05324631 ·Status: UNKNOWN ·Phase: PHASE3
-
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects
NCT07200596 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)
NCT07261644 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA)
NCT02985983 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects
NCT06883695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis
NCT00265083 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis
NCT02896127 ·Status: COMPLETED ·Phase: PHASE3
-
Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis
NCT00085644 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)
NCT01064856 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active Nr-axSpA
NCT05242588 ·Status: UNKNOWN ·Phase: PHASE2
-
ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis
NCT04795141 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis
NCT03928743 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis
NCT03178487 ·Status: COMPLETED ·Phase: PHASE2
-
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
NCT02159053 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy, Safety, and Pharmacokinetic Profile and Immunogenicity of Subcutaneous Netakimab in Chinese Adult Patients With Active Ankylosing Spondylitis
NCT07277179 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis
NCT00811499 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS)
NCT06242652 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis
NCT01358175 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of TJ003234 in Rheumatoid Arthritis Patients
NCT04457856 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis
NCT05467995 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
NCT07233655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients
NCT01001832 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis
NCT03928704 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of ACZ885 in Patients With Active Rheumatoid Arthritis
NCT00424346 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
NCT07349329 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3